Back

Results - Announcements

Sales decline 20.37% to Rs 3.01 crore

Shree Ganesh Biotech India reports standalone net loss of Rs 0.95 crore in the March 2025 quarter

23-May-2025, 07:44
Net loss of Shree Ganesh Biotech India reported to Rs 0.95 crore in the quarter ended March 2025 as against net profit of Rs 0.54 crore during the previous quarter ended March 2024. Sales declined 20.37% to Rs 3.01 crore in the quarter ended March 2025 as against Rs 3.78 crore during the previous quarter ended March 2024.

For the full year,net profit declined 54.84% to Rs 0.28 crore in the year ended March 2025 as against Rs 0.62 crore during the previous year ended March 2024. Sales rose 13.21% to Rs 22.96 crore in the year ended March 2025 as against Rs 20.28 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	3.01	3.78	-20	22.96	20.28	13
OPM %	-47.18	-13.76	-	-4.57	-1.04	-
PBDT	-0.95	0.54	PL	0.39	0.85	-54
PBT	-0.95	0.54	PL	0.39	0.85	-54
NP	-0.95	0.54	PL	0.28	0.62	-55